New Data Published in the Journal of Infectious Diseases Dem

New Data Published in the Journal of Infectious Diseases Demonstrate FluGen's M2SR Vaccine Candidate Substantially Enhances Mucosal & Serum Antibodies Against Drifted Influenza Strains

/PRNewswire/ -- FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the...

Related Keywords

Tokyo , Japan , Belgium , Yoshihiro Kawaoka , Pabout Flugen , Flugen Inc , Infectious Diseases , Influenza Research Institute , Medical Science , Single Replication , Vaccine Provides Enhanced Mucosal , Serum Antibodies , Live Virus Vaccine ,